2009, Número 1
<< Anterior Siguiente >>
Rev Med Inst Mex Seguro Soc 2009; 47 (1)
Impacto de la función renal retardada en la sobrevida del injerto renal de donador de cadáver
Piñón-Escobedo J, Bueno-Contreras JH, Esparza-Chávez ER, Gómez-García A, Rodríguez-Ayala E, Álvarez-Aguilar C
Idioma: Español
Referencias bibliográficas: 34
Paginas: 33-38
Archivo PDF: 107.11 Kb.
RESUMEN
Objetivo: determinar si la función renal retardada (FRR) se asocia con disminución en la sobrevida del injerto renal y cuáles factores predicen su desarrollo.
Métodos: se estudiaron 58 receptores de injerto renal de donador de cadáver. Se consideró FRR del injerto al no descenso de la creatinina plasmática en la primera semana postrasplante, requerir más de una sesión de diálisis o volumen urinario menor a 1 L/día por más de dos jornadas consecutivas.
Resultados: la curva de Kaplan-Meier y Log rank demostraron que FRR › 15 días se asoció con reducción en la sobrevida del injerto (Log rank = 4.15,
p = 0.042). El análisis de regresión logística demostró que el tiempo de isquemia fría › 12 horas (OR ajustada = 7.99, IC 95 % = 2.36-27.04,
p = 0.001) y la diálisis › 3 años (OR ajustada 1.67, IC 95 % = 1.14-3.47,
p = 0.032) se asociaron con FRR del injerto.
Conclusiones: FRR › 15 días se asoció con reducción en la sobrevida del injerto renal y favoreció la presencia de otros factores que reducen la sobrevida del injerto. El tiempo de isquemia fría › 12 horas y el tiempo en diálisis de los receptores › 3 años favorecieron FRR del injerto.
REFERENCIAS (EN ESTE ARTÍCULO)
Brook NR, White SA, Waller JR, Veitch PS, Nicholson ML. Non-heart beating donor kidneys with delayed graft function have superior graft survival compared with conventional heart-beating donor kidneys that develop delayed graft function. Am J Transplant 2003;3(5):614-618.
Brennan TV, Freise CE, Fuller TF, Bostrom A, Tomlamovich SJ, Feng S. Early graft function after living donor kidney transplantation predicts rejection but not outcomes. Am J Transplant 2004;4(6):971-979.
Koning OH, Ploeg RJ, van Bockel JH, Groenewegen M, van der Woude FJ, Persijn GG, et al. Risk factors for delayed graft function in cadaveric kidney transplantation. A prospective study of renal function and graft survival after preservation with University of Wisconsin solution in multi-organ donors. European Multicenter Study Group. Transplantation 1997;63(11):1620-1628.
Koning AHJ, van Bochel JH, van de Woude FJ, Persijn GG, Hernans J, Ploeg RJ. Risk factors for delayed function in University of Wisconsin solution preserved kidneys from multiorgan donors. European Multicenter Study Group on Organ Preservation. Transplant Proc 1995;27(1):752-753.
Rodrigo E, Ruiz JC, Pineda C, Fernández FG, Escallada R, Palomar R, et al. Creatinine reduction ratio on post-transplant day two as criterion in defining delayed graft function. Am J Transplant 2004;4(7):1163-1169.
Cole E, Naimark D, Aprile M, Wade J, Cattran D, Pei Y, et al. An analysis of predictors of long-term cadaveric renal allograft survival. Clin Transplant 1995;9(4):282-288.
Halloran P, Aprile M, Factors influencing early renal function in cadaver kidney transplants: a case control study. Transplantation 1988;45(1):122-127.
Southard JH, Belzer FO. Organ preservation. Annu Rev Med 1995;46:235-247.
Belli LS, De Carlis L, Del Favero E, Civati G, Brando B, Romani F, et al. The role of donor and recipient factors in initial renal graft non-function. Transplant Proc 1988;20(5):861-864.
He X, Johnston A. Risk factors for allograft failure in United Kingdom renal transplant recipients treated with cyclosporine A. Transplantation 2005;79(8):953-957.
Sanfilippo F, Vaughn WK, Spees EK, Lucas BA. The detrimental effects of delayed graft function in cadaver donor renal transplantation. Transplantation 1984;3(6)8:643-648.
Shackleton CR, Keown PA, McLoughin MG, Nigro MK, Meloche RM, Schudamore CH, et al. Cadaveric kidney transplantation with minimal delayed function: experience with perioperative strategies to enhance initial renal allograft function. Transplant Proc 1995;27(1):1075-1077.
Ricart MJ, Andreu J, Oppenheimer F, Vilardell J, Sans A, Orihuela S. Acute renal failure after renal transplantation under various immunosuppressive regimens. Transplant Proc 1988;20(5 Suppl 6):36-37.
Pieringer H, Biesenbach G. Risk factor for delayed kidney function and impact of delayed function on patient and graft survival in adult graft recipients. Clin Transplant 2005;19(3):391-398.
Iwaki Y, Iguro T, Terasaki PI. Nonfunctional kidneys in immunized patients. Transplant Proc 1985;17:2449-2451.
Rosenthal JT, Donovitch GM, Wilkinson A, Ettenger RB. The high cost of delayed graft function in cadaveric renal transplantation. Transplantation 1991;51(5):1115-1118.
Almost PS, Troppmann C, Escobar F, Frey DJ, Matas AJ. Economic impact of delayed graft function. Transplant Proc 1991;23(1 Pt 2):1304.
Kyllonen LE, Salmela KT, Eklund BH, Halme LE, Hockerstedt KA, Isoniemi HM, et al. Long-term results of 1047 cadaveric kidney transplantations with special emphasis on initial graft function and rejection. Transplant Int 2000;13(2):122-128.
Feldman HI, Gayner R, Berlin JA, Roth DA, Silibovsky R, Kushner S, et al. Delayed function reduces renal allograft survival independent of acute rejection. Nephrol Dial Transplant 1996;11(7): 1306-1313.
Giral-Classe M, Hourmant M, Cantrovich D, Dantal J, Blancho G, Daguin P, et al. Delayed graft function of more than six days strongly decreases long-term survival of transplanted kidneys. Kidney Int 1998;54(3):972-978.
Marcen R, Orofino L, Pascual J, de La Cal MA, Teruel JL, Villafruela JJ, et al. Delayed graft function does not reduce the survival of renal transplant allografts. Transplantation 1998;66(4):461-466.
Boom H, Mallat MJ, de Fijter JW, Zwinderman AH, Paul LC. Delayed graft function influences renal function, but not survival. Kidney Int 2000;58:859-866.
Hariharan S, McBride MA, Cherikh WS, Tolleris CB, Bresnahan BA, Johnson CP. Post-transplant renal function in the first year predicts long-term kidney transplant survival. Kidney Int 2002;62(1):311-318.
Meier-Kriesche HU, Kaplan B. Waiting time on dialysis as the strongest modifiable risk factor for renal transplant outcomes: a paired donor kidney analysis. Transplantation 2002;74(1):1377-1381.
Tejani AH, Sullivan EK, Alexander SR, Fine RN, Harmon WE, Kohaut EC. Predictive factors for delayed graft function (DGF) and its impact on renal graft survival in children: a report of the North American Pediatric Renal Transplant Cooperative Study (NAPRTCS). Pediatric Transplant 1999;3(4): 293-300.
Cecka ML, Cho WC, Terasaki PI. Analysis of the UNOS scientific renal transplant registry at three years-early events affecting transplant success. Transplantation 1992;53(1):59-64.
Lehtonen SR. Isoniemi HM, Salmela KT, Taskinen EI, von Willebrand EO, Ahonen JP. Long term graft outcome is not necessarily affected by delayed onset of graft function and early acute rejection. (Clinical transplantation). Transplantation 1997;64:103-107.
Joosten SA, Sijpkens YWJ, Paul LC. Chronic rejection in renal transplantation. Transplant Rev 2003;17:118-130.
Bruijne M, Sijpkens Y, Paul K, Westendorp R, Van Houwelingen H, Zwinderman A. Predicting kidney graft failure using time-dependent renal function covariates. J Clin Epidemiol 2003;56(5):448-455.
Howard RJ, Pfatt WW, Brunson ME, Ramos EL, Peterson JC, Croker BP, et al. Delayed graft function is associated with an increased of occult rejection and results in poorer graft survival. Transplant Proc 1993;(1Pt 2):884.
Pascual M, Theruvath T, Kawai T, Tolkoff-Rubin B, Cosimi AB. Strategies to improve long-term outcomes after renal transplantation. N Engl J Med 2002;346(8):580-590.
Opelz G, Döhler B. Improved long-term outcomes after renal transplantation associated with blood pressure control. Am J Transplant 2005;5(11):2725-2731.
Ojo AO, Wolfe RA, Held PJ, Port FK, Schmouder RL. Delayed graft function: risk factors and implications for renal allograft survival. Transplantation 1997;63(4):968-974.
Caravaca CF, Cubero JJ, García MC, Espárrago JF. Factores predictivos sobre el retraso inicial de la función del injerto renal: ¿juega algún papel significativo el hiperparatiroidismo secundario? Nefrologia 1995;15(6):587-591.